Over one-third of African-American MGUS and multiple myeloma patients are carriers of hyperphosphorylated paratarg-7, an autosomal dominantly inherited risk factor for MGUS/MM

Int J Cancer. 2014 Aug 15;135(4):934-8. doi: 10.1002/ijc.28731. Epub 2014 Feb 4.

Abstract

As hyperphosphorylated paratarg-7 (pP-7) carrier state was shown to be the first molecularly defined autosomal dominantly inherited risk factor for monoclonal gammopathy of unknown significance (MGUS) and multiple myeloma (MM) in a European population, the prevalence of pP-7 carrier state among African-Americans who have a significantly higher incidence of MGUS/MM is of interest. We therefore determined pP-7 carrier state and paraproteins with specificity for P-7 in African-American, European and Japanese patients with MGUS/MM and healthy controls. By isoelectric focusing and ELISA, a paratarg-7-specific paraprotein and the associated pP-7 carrier state was observed in 30/81 (37.0%) African-American, 42/252 (16.7%) European and 7/176 (4.0%) Japanese MGUS/MM patients (p < 0.001). A pP-7 carrier state was found in 11/100 (11.0%) African-American, 8/550 (1.5%) European and 1/278 (0.4%) Japanese healthy controls (p < 0.001), resulting in an odds ratio for MGUS/MM of 4.8 (p < 0.001) among African-American, 13.6 among European (p < 0.001) and 11.5 (p = 0.023) among Japanese carriers of pP-7. We conclude that pP-7 carriers are most prevalent among African-Americans, but a pP-7 carrier state is the strongest molecularly defined single risk factor for MGUS/MM known to date in all three ethnic groups. The high prevalence of pP-7 carriers among African-American patients emphasizes a predominant role of this genetic factor in the pathogenesis of these diseases. The large number of pP7 African-American patients and controls should facilitate the identification of the SNP or mutation underlying the pP-7 carrier state.

Keywords: MGUS; genetics; multiple myeloma; risk factors.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Black or African American
  • Case-Control Studies
  • Europe
  • Genes, Dominant
  • Heterozygote*
  • Humans
  • Isoelectric Focusing
  • Japan
  • Middle Aged
  • Monoclonal Gammopathy of Undetermined Significance / ethnology*
  • Monoclonal Gammopathy of Undetermined Significance / genetics*
  • Multiple Myeloma / ethnology*
  • Multiple Myeloma / genetics*
  • Mutation
  • Odds Ratio
  • Paraproteins / genetics*
  • Phosphorylation
  • Polymorphism, Single Nucleotide
  • Prevalence
  • Protein Phosphatase 2 / genetics*
  • Risk Factors
  • United States

Substances

  • Paraproteins
  • PPP2CA protein, human
  • Protein Phosphatase 2